期刊档案

ONCOLOGY RESEARCH

— · ISSN 0965-0407 · 医学-肿瘤学

数据可追溯 · letpub-v6 · 更新于 2026-08-26
影响指标4.65
h-index52
平均审稿速度网友分享经验:平均3月
平均录用比例网友分享经验:约75%

期刊简介

研究范围与定位

Oncology Research is committed to publishing high-quality, innovative research that is focused on the entire range of basic, translational, and clinical cancer research, with a particular interest in cancer therapeutics.Specific areas of interest include but are not limited to: identification of potential targets for cancers and the exploration of novel molecular mechanisms of tumorigenesis and metastasis; development of novel small molecules and targeted therapies;mechanisms of drug sensitivity; mechanisms of cellular drug resistance; biomarkers of response and/or resistance; novel experimental model systems and technologies relating to cancer therapeutics; pharmacogenetics and pharmacogenomics; personalized medicine; cancer stem cell; immunotherapy and clinical immunology; gene therapy; and radiobiology and novel approaches to radiation therapy either alone or in combination with chemotherapy. For studies that investigate the role of non-coding RNAs as regulators of cellular gene expression, it will be important for more in-depth mechanistic studies to be conducted that confirm their biological activity and their potential effect as mediators of chemosensitivity. The journal also embraces preclinical studies that are focused on drug design, chemical biology, and drug screening. In addition, submissions that investigate the potential role of herbal/botanical medicines in preclinical and clinical cancer therapy are welcomed; however, it will be important to document that these medicines are of high quality, with confirmation of batch-to-batch consistency. In addition to original peer-reviewed articles, the journal also welcomes timely reviews, case reports, editorials, analyses, letters and other types of manuscripts.

结构化分区

学科分区明细

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值。

《新锐期刊分区表》( 2026年3月发布)

2026-03 · 2 个学科记录

Top:否综述:N/A
类别学科分区
大类医学2区
小类肿瘤学ONCOLOGY2区

期刊分区表( 2025年3月升级版)

2025-03 · 2 个学科记录

Top:否综述:否
类别学科分区
大类医学4区
小类肿瘤学ONCOLOGY4区

期刊分区表( 2023年12月旧的升级版)

2023-12 · 2 个学科记录

Top:否综述:否
类别学科分区
大类医学4区
小类肿瘤学ONCOLOGY4区

期刊档案

出版与身份

期刊ISSN
0965-0407
E-ISSN
1555-3906
是否OA开放访问
Yes
通讯方式
2520 St. Rose Parkway, Suite 108D, Henderson, Nevada, 89074, USA
出版商
TECH SCIENCE PRESS
出版国家或地区
UNITED STATES
出版语言
English
出版周期
Monthly
出版年份
1992

期刊档案

研究范围

期刊简介
Oncology Research is committed to publishing high-quality, innovative research that is focused on the entire range of basic, translational, and clinical cancer research, with a particular interest in cancer therapeutics.Specific areas of interest include but are not limited to: identification of potential targets for cancers and the exploration of novel molecular mechanisms of tumorigenesis and metastasis; development of novel small molecules and targeted therapies;mechanisms of drug sensitivity; mechanisms of cellular drug resistance; biomarkers of response and/or resistance; novel experimental model systems and technologies relating to cancer therapeutics; pharmacogenetics and pharmacogenomics; personalized medicine; cancer stem cell; immunotherapy and clinical immunology; gene therapy; and radiobiology and novel approaches to radiation therapy either alone or in combination with chemotherapy. For studies that investigate the role of non-coding RNAs as regulators of cellular gene expression, it will be important for more in-depth mechanistic studies to be conducted that confirm their biological activity and their potential effect as mediators of chemosensitivity. The journal also embraces preclinical studies that are focused on drug design, chemical biology, and drug screening. In addition, submissions that investigate the potential role of herbal/botanical medicines in preclinical and clinical cancer therapy are welcomed; however, it will be important to document that these medicines are of high quality, with confirmation of batch-to-batch consistency. In addition to original peer-reviewed articles, the journal also welcomes timely reviews, case reports, editorials, analyses, letters and other types of manuscripts.
涉及的研究方向
医学-肿瘤学

期刊档案

指标与活跃度

2025-2026最新IF(数据来源于网友提供)
注册或登录后,查看IF
实时影响因子
截止2026年5月06日:4.65
2025-2026自引率
2.2%点击查看自引率趋势图
五年IF(数据来源于网友提供)
4.097数据由网友[正午223]收集提供
h-index
52
CiteScore ( 2026年6月最新版)
CiteScoreSJRSNIPCiteScore排名4.101.1020.767学科分区排名百分位大类:Medicine小类:OncologyQ2210 / 428 51% 大类:Medicine小类:Cancer ResearchQ3153 / 233 34%
年文章数
232点击查看年文章数趋势图
Gold OA文章占比
57.05%
研究类文章占比:文章 ÷(文章 + 综述)
78.02%

期刊档案

分区、收录与风险

WOS期刊JCR分区 ( 2025-2026年最新版)
注册或登录后,查看WOS分区等级
期刊分区表预警名单
2026年03月发布的新锐学术版:不在预警名单中2025年03月发布的2025版:不在预警名单中2024年02月发布的2024版:不在预警名单中2023年01月发布的2023版:不在预警名单中2021年12月发布的2021版:不在预警名单中2020年12月发布的2020版:预警等级:中
SCI期刊收录coverage
Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)Scopus (CiteScore)
PubMed Central (PMC)链接
访问官方页面 ↗

期刊档案

投稿与评审

期刊官方网站
访问官方页面 ↗
期刊投稿网址
访问官方页面 ↗
作者指南网址
访问官方页面 ↗
平均审稿速度
网友分享经验:平均3月
平均录用比例
网友分享经验:约75%

来源与统计口径

来源:LetPub 原始详情页 ↗。投稿经验仅展示聚合统计,不公开第三方正文或用户标识。当前聚合样本:暂无。